Article

Axial Spondyloarthritis More Common than Previously Thought

Axial spondyloarthritis (SpA) often goes undiagnosed and is more common than previously thought, a study shows.

Researchers writing in the July 2016 issue of Arthritis and Rheumatology show that axial spondyloarthritis (SpA) is more common among patients being treated for chronic back pain than previously thought.

Of 697 patients enrolled in this multi-center, non-drug treatment, single visit study conducted at rheumatology practices in the U.S., 319 (46%) were diagnosed as having axial SpA and 348 of 744 (47%) fulfilled the ASAS criteria - of whom 238 were classified as having nonradiographic axial SpA and 108 as having ankylosing spondylitis (AS).

The study, called the Prevalence of Axial SpA (PROSpA) study, was conducted to determine the proportion of patients with nonradiographic axial SpA among those with chronic back pain for at least three months. The patients were 45 years old or younger and were identified with at least one of the following diagnosis criteria:  HLA–B27 positivity, current inflammatory back pain, and imaging (magnetic resonance imaging [MRI] or radiographic) evidence of sacroiliitis.  [[{"type":"media","view_mode":"media_crop","fid":"49865","attributes":{"alt":"©Mirana/Shutterstock.com","class":"media-image media-image-right","id":"media_crop_9876619203526","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"6062","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"font-size: 13.008px; line-height: 1.538em; float: right;","title":"©Mirana/Shutterstock.com","typeof":"foaf:Image"}}]]

“Overall, these findings emphasize the need to improve the identification and diagnosis of both AS and nonradiographic axial SpA among patients already receiving care in rheumatology practices and those newly referred to rheumatologists,” wrote the researchers who were led by Atul Deodhar, M.D., of Oregon Health & Science University in Portland.

“Increased disease awareness and the use of appropriate referral criteria can reduce the delay to diagnosis and provide a better understanding of the prevalence of axial SpA. These patients experience a similar burden of disease and their disease can remain undiagnosed and, therefore untreated, for many years,” the authors wrote.

Both ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA) typically go undiagnosed for years. Although AS and nonradiographic axial SpA have comparable clinical manifestations, AS is more easily identified by the presence of sacroiliitis on radiographs.

Nonradiographic axial SpA may affect as many women as men, whereas AS more often affects men.

“The delay to diagnosis of axial SpA can be partly attributed to delayed referral to rheumatologists,” the authors wrote.

 

Disclosures:

The study was funded by AbbVie

 

References:

"Frequency of Axial Spondyloarthritis Diagnosis AmongPatients Seen by US Rheumatologists for Evaluation of Chronic Back Pain." Arthritis & Rheumatology.  Vol. 68, No. 7, July 2016, pp 1669–1676DOI 10.1002/art.39612

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.